
Genetron Holdings Limited GTH
Annual report 2022
added 12-21-2024
Genetron Holdings Limited ROCE Ratio 2011-2026 | GTH
Annual ROCE Ratio Genetron Holdings Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -15.41 | -85.06 | -90.77 | -38.95 | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -15.41 | -90.77 | -57.55 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | ||
|
Agilent Technologies
A
|
25.0 | $ 115.58 | 0.45 % | $ 35.1 B | ||
|
Celcuity
CELC
|
-171.24 | $ 132.39 | -1.4 % | $ 6.19 B | ||
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-236.6 | $ 7.51 | -17.56 % | $ 9.99 M | ||
|
Castle Biosciences
CSTL
|
-9.09 | $ 21.34 | 8.38 % | $ 619 M | ||
|
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
63.01 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | ||
|
Fulgent Genetics
FLGT
|
-8.19 | $ 17.56 | -0.65 % | $ 540 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
-10.16 | $ 21.63 | 0.42 % | $ 1.15 B | ||
|
Guardant Health
GH
|
440.3 | $ 122.77 | 2.43 % | $ 15.4 B | ||
|
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-69.04 | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | ||
|
Interpace Biosciences
IDXG
|
18.26 | $ 1.8 | - | $ 7.96 M | ||
|
ICON Public Limited Company
ICLR
|
11.53 | $ 117.97 | 3.62 % | $ 9.73 B | ||
|
Illumina
ILMN
|
-35.1 | $ 144.89 | -0.23 % | $ 23 B | ||
|
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | ||
|
Lantheus Holdings
LNTH
|
28.52 | $ 99.54 | -0.52 % | $ 6.72 B | ||
|
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B | ||
|
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
0.8 | $ 163.83 | 4.65 % | $ 8.12 B | ||
|
Mettler-Toledo International
MTD
|
35.8 | $ 1 099.36 | -0.18 % | $ 22.7 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | ||
|
NeoGenomics
NEO
|
-9.11 | $ 9.46 | 2.05 % | $ 1.21 B | ||
|
Medpace Holdings
MEDP
|
116.53 | $ 433.51 | 1.02 % | $ 12.5 B | ||
|
National Research Corporation
NRC
|
161.47 | $ 19.15 | 0.58 % | $ 429 M | ||
|
Natera
NTRA
|
-76.66 | $ 199.66 | -0.62 % | $ 19.6 B | ||
|
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
-105.22 | $ 3.87 | 0.52 % | $ 358 M | ||
|
Personalis
PSNL
|
-33.71 | $ 8.97 | 0.34 % | $ 800 M | ||
|
Koninklijke Philips N.V.
PHG
|
7.33 | $ 26.61 | -1.28 % | $ 25.2 B | ||
|
Senseonics Holdings
SENS
|
-111.94 | $ 6.29 | -2.18 % | $ 262 M | ||
|
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
2.09 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
-125.14 | $ 2.38 | -3.73 % | $ 5.47 M | ||
|
Twist Bioscience Corporation
TWST
|
-28.81 | $ 64.28 | -0.91 % | $ 3.84 B | ||
|
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 259.15 | 0.28 % | $ 21.6 B | ||
|
Thermo Fisher Scientific
TMO
|
14.5 | $ 450.44 | 0.49 % | $ 170 B | ||
|
Waters Corporation
WAT
|
7.05 | $ 343.56 | 1.44 % | $ 20.5 B | ||
|
Trinity Biotech plc
TRIB
|
-29.73 | $ 0.66 | 2.61 % | $ 237 M | ||
|
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
-51.22 | $ 9.26 | 1.26 % | $ 2.01 B | ||
|
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 194.51 | 0.83 % | $ 21.6 B |